CCXI - ChemoCentryx Inc
Previous close
51.99
0 0%
Share volume: 0
Last Updated: Wed 19 Oct 2022 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$51.99
0.00
0.00%
Summary score
39%
Profitability
32%
Dept financing
16%
Liquidity
29%
Performance
55%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-20.46%
Return on assets
-3.83%
Return on sales
0%
Return on invested capital
16.39%
Total debt ratio
69.75%
Debt ratio change over timeo
1.23%
Current Ratio
3.62%
Quick Ratio
0%
Cash Position Ratio
0.98%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-18.88%
Return on assets
-5.4%
Return on sales
0%
Return on invested capital
24.58%
Total debt ratio
57.77%
Debt ratio change over timeo
-0.06%
Current Ratio
4.57%
Quick Ratio
0%
Cash Position Ratio
2.06%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
4.81%
Return on assets
3.76%
Return on sales
0%
Return on invested capital
-94.1%
Total debt ratio
22.3%
Debt ratio change over time
-0.51%
Current Ratio
9%
Quick Ratio
0%
Cash Position Ratio
5.91%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-158.26%
Return on assets
-106.86%
Return on sales
0%
Return on invested capital
-88.17%
Total debt ratio
122.96%
Debt ratio change over time
1.23%
Current Ratio
10.34%
Quick Ratio
0%
Cash Position Ratio
1.98%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | CCXI | VLON | ELAT | RETA |
---|---|---|---|---|
Return on equity | -20.46% | 0% | 0% | 29.06% |
Return on assets | -3.83% | 0% | 0% | -9.75% |
Return on sales | 0% | 0% | 0% | -1469.44% |
Return on invested capital | 16.39% | 0% | 0% | 47.78% |
Profitability | 34% | 0% | 25% | 50% |
Total debt ratio | 69.75% | 0% | 0% | 183.15% |
Debt ratio change over time | 1.23% | 0% | 0% | 19.02% |
Dept financing | 11% | 0% | 0% | 50% |
Current Ratio | 4.57% | 0% | 0% | 5.9% |
Quick Ratio | 0% | 0% | 0% | 5.9% |
Cash Position Ratio | 2.06% | 0% | 0% | 5.68% |
Liquididy | 29% | 0% | 0% | 75% |
Short-term ratios | CCXI | VLON | ELAT | RETA |
---|---|---|---|---|
Return on equity | -18.88% | 0% | 0% | -16.12% |
Return on assets | -5.4% | 0% | 0% | -14.95% |
Return on sales | 0% | 0% | 0% | -3498.94% |
Return on invested capital | 24.58% | 0% | 0% | 96.56% |
Profitability | 31% | 0% | 50% | 25% |
Total debt ratio | 57.77% | 0% | 0% | 79.61% |
Debt ratio change over time | -0.06% | 0% | 0% | 0.09% |
Dept financing | 18% | 0% | 0% | 50% |
Current Ratio | 4.57% | 0% | 0% | 5.9% |
Quick Ratio | 0% | 0% | 0% | 5.9% |
Cash Position Ratio | 2.06% | 0% | 0% | 5.68% |
Liquididy | 28% | 0% | 0% | 75% |